Crinetics Pharmaceuticals, Inc.

NASDAQ:CRNX

30.11 (USD) • At close May 22, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Revenue 0.361000.3990.6400.3460.9882.6790.7090.4580.4393.1311.0780000000.0710.3210.50500.3670.7810.5480.6570.4420.5280.640.8320.045
Cost of Revenue 00.78800.7530.4740.2620.2730.3980.3980.3880.3510.3150.3351.0770.3190.3130.30416.8313.69912.60713.86212.14311.82310.2857.2557.6516.8865.2224.722.5622.5232.0832.065
Gross Profit 0.36100-0.3540.166-0.2620.0730.592.2810.3210.1070.1242.7960.001-0.319-0.313-0.304-16.83-13.699-12.607-13.791-11.822-11.318-10.285-6.888-6.87-6.338-4.565-4.278-2.034-1.883-1.251-2.02
Gross Profit Ratio 100-0.8870.25900.2110.5970.8510.4530.2340.2820.8930.001000-237,042,253,521,125.8-2,882,786,194.2860-194.239-36.829-22.4120-18.768-8.796-11.566-6.948-9.679-3.852-2.942-1.504-44.889
Reseach & Development Expenses 76.2466.56661.90558.34452.86745.31843.83940.6438.46836.99131.98732.99528.25224.60421.5820.48717.58416.8313.69912.60713.86212.14311.82310.2857.2557.6516.8865.2224.722.5622.5232.0832.065
General & Administrative Expenses 35.52628.17925.89224.83820.82817.07815.48413.34312.18911.27411.92510.4898.7067.3626.2275.6025.3344.9614.7524.3223.9913.3923.9113.063.1562.5611.7321.1181.2480.4670.4910.3920.589
Selling & Marketing Expenses 000000000000000000000000000000000
SG&A 35.52628.17925.89224.83820.82817.07815.48413.34312.18911.27411.92510.4898.7067.3626.2275.6025.3344.9614.7524.3223.9913.3923.9113.063.1562.5611.7321.1181.2480.4670.4910.3920.589
Other Expenses 0000-0.2510.042.516-0.0911.9832.5650.029-0.0810.0170.094-0.068-0.029-0.0130.150.0090.178-0.1340.665-0.036-0.0420.0180.936-0.052-0.036-0.002-0.025-0.012-0.009-0.002
Operating Expenses 111.76694.74587.79783.18273.69562.39659.32353.98350.65748.26543.91243.48436.95831.96627.80726.08922.91821.79118.45116.92917.78215.21415.22913.34510.0449.4318.075.6835.5262.5012.3741.6432.609
Operating Income -111.405-94.745-87.797-82.783-74.169-62.658-58.977-52.995-47.978-47.556-43.454-43.045-33.827-30.888-27.807-26.089-22.918-21.791-18.451-16.929-17.782-15.214-15.229-13.345-10.044-9.431-8.07-5.683-5.526-2.501-2.374-1.643-2.609
Operating Income Ratio -308.60100-207.476-115.8890-170.454-53.639-17.909-67.075-94.878-98.052-10.804-28.653000-306,915,492,957,746.56-3,882,786,195.2860-250.451-47.396-30.1560-27.368-12.076-14.726-8.65-12.502-4.737-3.709-1.975-57.978
Total Other Income Expenses Net 14.63114.1510.9698.7286.5992.5611.5192.0161.9832.5651.5290.67-0.80.094-0.044-0.0060.0170.150.1310.4380.4220.6650.7990.9181.0280.9360.4820.1150.062-0.02-0.008-0.0050.003
Income Before Tax -96.774-80.595-76.828-74.055-66.93-60.097-57.458-50.979-45.995-44.991-41.925-42.375-34.627-30.794-27.851-26.095-22.901-21.641-18.32-16.491-17.36-14.549-14.43-12.427-9.016-8.495-7.588-5.568-5.464-2.521-2.382-1.648-2.606
Income Before Tax Ratio -268.07200-185.602-104.5780-166.064-51.598-17.169-63.457-91.539-96.526-11.059-28.566000-304,802,816,901,408.5-3,855,218,855.2190-244.507-45.324-28.5740-24.567-10.877-13.847-8.475-12.362-4.775-3.722-1.981-57.911
Income Tax Expense 000000.218-0.273-2.107-1.983-2.565-1.529-0.670.8-107.627-0.024-0.023-0.03-0.225-0.122-0.26-0.556-0.229-0.835-0.96-1.01-0.208-0.052-0.036-0.002-0.024-0.01-0.0060
Net Income -96.774-80.595-76.828-74.055-66.93-60.097-57.458-50.979-44.012-42.426-40.396-41.705-35.427-30.794-27.851-26.095-22.901-21.641-18.32-16.491-17.36-14.549-14.43-12.427-9.016-8.495-7.588-5.568-5.464-2.521-2.382-1.648-2.606
Net Income Ratio -268.07200-185.602-104.5780-166.064-51.598-16.429-59.839-88.201-95-11.315-28.566000-304,802,816,901,408.5-3,855,218,855.2190-244.507-45.324-28.5740-24.567-10.877-13.847-8.475-12.362-4.775-3.722-1.981-57.911
EPS -1.04-0.88-0.96-0.94-0.93-0.9-1.01-0.94-0.82-0.79-0.75-0.79-0.75-0.68-0.73-0.7-0.69-0.66-0.56-0.53-0.71-0.6-0.6-0.51-0.37-0.35-0.38-0.25-0.25-0.18-0.17-0.12-0.19
EPS Diluted -1.04-0.88-0.96-0.94-0.93-0.9-1.01-0.94-0.82-0.79-0.75-0.79-0.74-0.68-0.73-0.7-0.69-0.66-0.56-0.53-0.71-0.6-0.6-0.51-0.37-0.35-0.38-0.25-0.25-0.18-0.17-0.12-0.19
EBITDA -110.48-93.957-87.027-82.03-73.055-62.396-58.704-52.715-47.695-47.276-43.206-42.83-33.587-30.653-27.574-25.859-22.694-21.566-18.207-16.685-17.547-14.985-15.001-13.115-9.844-8.287-7.931-5.607-5.478-2.472-2.352-1.62-2.577
EBITDA Ratio -306.03900-205.589-114.1480-169.665-53.355-17.803-66.68-94.336-97.563-10.727-28.435000-303,746,478,873,239.5-3,831,439,393.9390-247.141-46.682-29.7050-26.823-10.611-14.473-8.534-12.394-4.682-3.675-1.947-57.267